Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder

BACKGROUND: Effective management of major depressive disorder often includes the long-term use of multiple medications, and the longer-term utility and safety of adjunctive aripiprazole has not been evaluated in a controlled setting. PATIENTS AND METHODS: Patients (n = 706) completing one of two 14-...

Descripción completa

Detalles Bibliográficos
Autores principales: Berman, Robert M, Thase, Michael E, Trivedi, Madhukar H, Hazel, James A, Marler, Sabrina Vogel, McQuade, Robert D, Carson, William, Baker, Ross A, Marcus, Ronald N
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3104689/
https://www.ncbi.nlm.nih.gov/pubmed/21655344
http://dx.doi.org/10.2147/NDT.S18333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3104689/
https://www.ncbi.nlm.nih.gov/pubmed/21655344
http://dx.doi.org/10.2147/NDT.S18333

Ejemplares similares